Mast cell involvement in zymosan-induced peritonitis in C57Bl/6 mice

Central-European Journal of Immunology

Volumn 33, Issue 3, 2008, Pages 91-97

  Kołaczkowska, Elzbieta ^a   Arnold, Bernd ^b   Płytycz, Barbara ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Mast cells; MCP 1; Peritoneal inflammation; Peritonitis; Vasopermeability

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; LEUKOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; OMENTUM; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PERITONEAL FLUID; PERITONEUM EXUDATE; PERITONEUM MAST CELL; PERITONITIS; POLYMERASE CHAIN REACTION;

EID: 44449159845     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bachelet I, Levi-Schaffer F (2007): Mast cells as effector cells: a co-stimulating question. Trends Immunol 28: 360-365.
2. Galli SJ, Kalesnikoff J, Grimbaldeston MA et al. (2005): Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786.
3. Galli SJ, Tsai M, Wershil BK et al. (1995): Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 107: 51-53.
4. Kawakami T, Kitaura J, Xiao W, Kawakami Y (2005): IgE regulation of mast cell survival and function. Novartis Found Symp 271: 100-107.
5. Kinet JP (2007): The essential role of mast cells in orchestrating inflammation. Immunol Rev 217: 5-7.
6. Braga T, Grujic M, Lukinius A et al. (2007): Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J 403: 49-57.
7. Henningsson F, Hergeth S, Cortelius R et al. (2006): A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J 273: 4901-4012.
8. Forssell J, Sideras P, Eriksson C et al. (2005): Interleukin-2-inducible T cell kinase regulates mast cell degranulation and acute allergic responses. Am J Respir Cell Mol Biol 32: 511-520.
9. Stelekati E, Orinska Z, Bulfone-Paus S (2007): Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212: 505-519.
10. Dawicki W, Marshall JS (2007): New and emerging roles for mast cells in host defence. Curr Opin Immunol 19: 31-38.
11. Ajuebor MN, Das AM, Virág L et al. (1999): Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 162: 1685-1691.
12. Kolaczkowska E, Seljelid R, Plytycz B (2001): Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice. Inflamm Res 50: 415-421.
13. Kolaczkowska E, Seljelid R, Plytycz B (2001): Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J Leukoc Biol 69: 33-42.
14. Kolaczkowska E, Shahzidi S, Seljelid R et al. (2002): Early vascular permeability in murine experimental peritonitis is comediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26: 61-71.
15. Kolaczkowska E, Lelito M, Kozakiewicz E et al. (2007): Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells. Immunol Lett 113: 99-106.
16. Tchougounova E, Lundequist A, Fajardo I et al. (2005): A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280: 9291-9296.
17. Kolaczkowska E, Chadzinska M, Seljelid R, Plytycz B (2001): Strain differences in some immune parameters can be obscured by circadian variations and laboratory routines: studies of male C57BL/6J, Balb/c and CB6 F1 mice. Lab Anim 35: 91-100.
18. Kolaczkowska E, Barteczko M, Plytycz B et al. (2008): Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflamm Res (in press).
19. Stankiewicz E, Wypasek E, Plytycz B (2001): Opposite effects of mast cell degranulation by compound 48/80 on peritoneal inflammation in Swiss and CBA mice. Pol J Pharmacol 53: 149-155.
20. Stankiewicz E, Wypasek E, Plytycz B (2004): Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA mice. Mediators Inflamm 13: 365-368.
21. Kolaczkowska E (2002): Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes. Inflamm Res 51: 519-521.
22. Das AM, Flower RJ, Perretti M (1997): Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. J Immunol 159: 1466-1473.
23. Doherty NS, Poubelle P, Borgeat P et al. (1985): Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30: 769-789.
24. Kolaczkowska E, Scislowska-Czarnecka A, Chadzinska M et al. (2006): Enhanced early vascular permeability in gelatinase B (MMP-9)-deficient mice: putative contribution of COX-1-derived PGE2 of macrophage origin. J Leukoc Biol 80: 125-132.
25. Kolaczkowska E, Arnold B, Opdenakker G (2008): Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology 213: 109-124.
26. Chao AC, Shyu SS, Lin YC, Mi FL (2004): Enzymatic grafting of carboxyl groups on to chitosan - to confer on chitosan the property of a cationic dye adsorbent. Bioresour Technol 91: 157-162.
27. Edling CE, Hallberg B (2007): c-Kit - a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol 39: 1995-1998.
28. Reber L, Da Silva CA, Frossard N (2006): Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol 533: 327-340.
29. Sur R, Cavender D, Malaviya R (2007): Different approaches to study mast cell functions. Int Immunopharmacol 7: 555-567.
30. Dvorak AM, Tepper RI, Weller PF et al. (1994): Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 83: 3600-3612.
31. Oliani SM, Lim LH, Christian HC et al. (2001): Morphological alteration of peritoneal mast cells and macrophages in the mouse peritoneal cavity during the early phases of an allergic inflammatory reaction. Cell Biol Int 25: 795-803.
32. Röhlich P, Anderson P, Uvnäs B (1971): Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol 51: 465-483.
33. Brzezińska-Błaszczyk E, Pietrzak A, Misiak-Tłoczek AH (2007): Tumor necrosis factor (TNF) is a potent rat mast cell chemoattractant. J Interferon Cytokine Res 27: 911-919.
34. Nilsson G, Mikovits JA, Metcalfe DD, Taub DD (1999): Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood 93: 2791-2797.
35. Okayama Y, Kawakami T (2006): Development, migration, and survival of mast cells. Immunol Res 34: 97-115.
36. Nakayama T, Mutsuga N, Yao L, Tosato G (2006): Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J Leukoc Biol 79: 95-104.